🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to assess the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-05-26
Trial ID
NCT04535037
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Investigational Site Number : 0560004
Start Date
2025-05-22
Trial ID
NCT06975878
Treatments Being Tested
The purpose of this phase I study is to evaluate the safety of a Sabin Inac...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2017-08-21
Trial ID
NCT04264598
Treatments Being Tested
This is a study in a large number of healthy children less than 3 years old...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-28
Trial ID
NCT00466947
Intimate Partner Violence (IPV) is a major public health problem in low- an...
Status
Recruiting
Location
Possible
Start Date
2025-04-04
Trial ID
NCT06834867
Treatments Being Tested
Adverse childhood experiences (ACEs) are unfortunately common and the known...
Status
Completed
Location
Rapid City Family Project Office
Start Date
2021-10-09
Trial ID
NCT05129501
Treatments Being Tested
The study will compare the transmissible levels of poliovirus type-2 detect...
Status
Not Yet Recruiting
Location
icddr,b - Matlab Health Research Centre
Start Date
2025-12-08
Trial ID
NCT07010822
Treatments Being Tested
This is a randomized double-blind controlled study and was performed to com...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02808637
The goal of this clinical trial is to investigate the effect of booster vac...
Status
Active Not Recruiting
Location
RadboudUMC
Start Date
2024-10-16
Trial ID
NCT06903221
The purpose of this study is to select the optimal antigen dosage of the th...
Status
Terminated
Location
CEVAXIN - David
Start Date
2017-06-07
Trial ID
NCT03092791
Treatments Being Tested